March 15th 2023
Session moderators, speakers and audience members all will examine and analyse the most relevant and controversial issues within the field of ophthalmology.
BREAKING NEWS: Faricimab approved by U.S. FDA for treatment of wet AMD, DMO
January 29th 2022Genentech’s treatment of faricimab is the first and only FDA-approved medicine targeting two distinct pathways, angiopoietin (Ang)-2 and vascular endothelial growth factor (VEGF)-A, that often cause retinal diseases that may cause visual loss.
Genentech's Susvimo, formerly PDS with ranibizumab, receives US FDA approval
October 26th 2021Susvimo, formerly called the Port Delivery System with ranibizumab, is a first-of-its-kind therapeutic approach for wet AMD and may help people with the disease maintain their vision with as few as two treatments per year.
PDS with ranibizumab in nAMD offers similar results to ranibizumab monthly injections
October 11th 2021Dr Arshad Khanani reported at ASRS 2021 that the Port Delivery System with ranibizumab, an investigational product that continuously delivers ranibizumab intravitreally, achieved results similar to those in patients treated with monthly ranibizumab injections for nAMD.
Brolucizumab injection improves vision in eyes with neovascular AMD
September 11th 2021In a presentation at the EURETINA 2021 Virtual Congress, Dr Cristina Cristian noted that an injection of brolucizumab treatment in patients with neovascular age-related macular degeneration led to a median improvement in visual acuity (VA) of 10.5 letters and the drug was well-tolerated.
Inherited Retinal Disease: Treatment Overview
Dr Mariya Moosajee highlights therapies approved as well as under study to improve treatment for patients with inherited retinal disease.
Diabetic Macular Edema: Treatment Overview
A discussion regarding the roles of various treatments available for diabetic macular edema and considerations for selecting and sequencing therapy.
Age-Related Macular Degeneration: Treatment Overview
An overview of the current treatment landscape for age-related macular degeneration and factors that impact treatment selection.
Evaluating Patients for a Retinal Disorder
Types of tests and criteria that can be used to diagnose conditions such as age-related macular degeneration, diabetic macular edema, and inherited retinal disease.
Common Types of Retinal Disorders Explored
A panel of global experts who treat patients with retinal diseases suggest causes of age-related macular degeneration, diabetic macular edema, and inherited retinal disease.
Learning the basics of age-related macular degeneration
February 3rd 2021Ian C. Han, MD, assistant professor in the Department of Ophthalmology and Visual Sciences, Institute for Vision Research, University of Iowa Hospital and Clinics, dives into the basics of age-related macular degeneration (AMD) and what patients need to know.